Appendix S1 - Proteomic Profiling in Multiple Sclerosis Clinical Courses Reveals Potential Biomarkers of Neurodegeneration

Figure S1, Tables S1–S3. Figure S1: Examples of spectra in CIS subjects with the unidentified peak signal at 3817.45 m/z. Table S1: peak signals that discriminated between the MS subgroups. Table S2: list of already identified proteins enclosed in the m/z range of interest in our study. Table S3: comparisons of clinical and demographic features between CIS subjects who did not converted (CIS-CIS) and those who shifted to CDMS.
(DOCX)